ROYAL BANK OF CANADA - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 143 filers reported holding ENDOCYTE INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$105,000
+8.2%
5,870
-16.7%
0.00%
Q2 2018$97,000
+49.2%
7,0500.0%0.00%
Q1 2018$65,000
+18.2%
7,050
-45.3%
0.00%
Q4 2017$55,000
+103.7%
12,882
-30.8%
0.00%
Q3 2017$27,000
-81.6%
18,610
-81.0%
0.00%
Q2 2017$147,000
-53.5%
98,140
-20.2%
0.00%
Q1 2017$316,000
-8.7%
122,961
-9.5%
0.00%
Q4 2016$346,000
-21.4%
135,846
-4.4%
0.00%
Q3 2016$440,000
-9.5%
142,146
-6.0%
0.00%
Q2 2016$486,000
+3.6%
151,165
-0.0%
0.00%
Q1 2016$469,000
-27.8%
151,212
-6.6%
0.00%
Q4 2015$650,000
-25.2%
161,931
-14.7%
0.00%
-100.0%
Q3 2015$869,000
-13.1%
189,822
-1.5%
0.00%0.0%
Q2 2015$1,000,000
+97.2%
192,646
+138.0%
0.00%
Q1 2015$507,000
-10.9%
80,944
-10.5%
0.00%
Q4 2014$569,000
+2.3%
90,437
-1.1%
0.00%
Q3 2014$556,000
-6.6%
91,402
+1.2%
0.00%
Q2 2014$595,000
-75.5%
90,317
-11.4%
0.00%
-100.0%
Q1 2014$2,426,000
+182.4%
101,885
+26.7%
0.00%
+100.0%
Q4 2013$859,000
+39.4%
80,426
+73.9%
0.00%
Q3 2013$616,000
+14.3%
46,260
+12.6%
0.00%
Q2 2013$539,00041,0720.00%
Other shareholders
ENDOCYTE INC shareholders Q3 2018
NameSharesValueWeighting ↓
VHCP Management II, LLC 4,300,000$59,340,00017.76%
RA Capital Management 5,649,884$77,968,0005.06%
Avoro Capital Advisors LLC 5,695,200$78,594,0003.03%
Crosspoint Capital Strategies, LLC 107,620$1,485,0002.84%
Ghost Tree Capital, LLC 500,000$6,900,0002.03%
EMORY UNIVERSITY 205,295$2,833,0001.88%
Asymmetry Capital Management, L.P. 103,159$1,424,0001.40%
NEXTHERA CAPITAL LP 596,000$8,225,0001.27%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,324,299$32,075,0001.13%
PFM Health Sciences, LP 4,068,608$56,147,0000.88%
View complete list of ENDOCYTE INC shareholders